Purpose of Review <p>This review explores age-related differences in rhinitis, focusing on allergic and non-allergic subtypes, including vasomotor, atrophic, hormonal, and geriatric rhinitis. Understanding these distinctions is essential for optimizing diagnosis and treatment.</p> Recent Findings <p>Allergic rhinitis is prevalent in children due to immune development and environmental sensitization, while non-allergic rhinitis dominates in adults and the elderly, influenced by mucosal atrophy and chronic exposures. Advances in pharmacotherapy, immunotherapy, and minimally invasive surgical techniques have improved symptom control. Immunotherapy remains the only disease-modifying treatment. Emerging research on genetic predispositions and biomarkers may lead to personalized approaches.</p> Summary <p>Rhinitis significantly impacts quality of life across age groups. Management strategies should be tailored to the patient’s age, integrating environmental controls, pharmacologic therapies, and surgical options when needed. Future research should refine diagnostic criteria and explore novel therapies, including precision medicine. A deeper understanding of age-related rhinitis variations will enhance clinical outcomes and improve patient care across the lifespan.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Age-Related Rhinitis: A Comparative Review in Adults and Children

  • Alessandra Cataldo Russomando,
  • Yvonne Chan,
  • Nikolaus E Wolter

摘要

Purpose of Review

This review explores age-related differences in rhinitis, focusing on allergic and non-allergic subtypes, including vasomotor, atrophic, hormonal, and geriatric rhinitis. Understanding these distinctions is essential for optimizing diagnosis and treatment.

Recent Findings

Allergic rhinitis is prevalent in children due to immune development and environmental sensitization, while non-allergic rhinitis dominates in adults and the elderly, influenced by mucosal atrophy and chronic exposures. Advances in pharmacotherapy, immunotherapy, and minimally invasive surgical techniques have improved symptom control. Immunotherapy remains the only disease-modifying treatment. Emerging research on genetic predispositions and biomarkers may lead to personalized approaches.

Summary

Rhinitis significantly impacts quality of life across age groups. Management strategies should be tailored to the patient’s age, integrating environmental controls, pharmacologic therapies, and surgical options when needed. Future research should refine diagnostic criteria and explore novel therapies, including precision medicine. A deeper understanding of age-related rhinitis variations will enhance clinical outcomes and improve patient care across the lifespan.